Revolution Medicines, Inc. (RVMD)
98.27
+2.29
(+2.39%)
USD |
NASDAQ |
Feb 11, 15:35
Revolution Medicines EPS Diluted (Quarterly) : -1.613 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| AbbVie, Inc. | 1.024 |
| Eli Lilly & Co. | 7.390 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Solid Biosciences, Inc. | -0.4848 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -305.21M |
| Total Expenses (Quarterly) | 305.21M |
| Enterprise Value | 16.78B |
| Earnings Yield | -5.27% |
| Normalized Earnings Yield | -5.261 |